Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
liečivo je fosaprepitant.
the active substance is fosaprepitant.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
tabuľkový zoznam nežiaducich reakcií – fosaprepitant
tabulated list of adverse reactions – fosaprepitant
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Čo ivemend obsahuje • liečivo je fosaprepitant.
what ivemend contains • the active substance is fosaprepitant.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
ivemend 150 mg prášok na infúzny roztok fosaprepitant
ivemend 150 mg powder for solution for infusion fosaprepitant
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
liek obsahuje účinnú látku fosaprepitant (150 mg).
it contains the active substance fosaprepitant (150 mg).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
fosaprepitant sa pri intravenóznom podaní rýchlo mení na aprepitant.
when administered intravenously fosaprepitant is rapidly converted to aprepitant.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
ivemend je prášok obsahujúci 115 mg účinnej látky fosaprepitant.
ivemend is a powder containing 115 mg of the active substance fosaprepitant.
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
Účinná látka lieku ivemend, fosaprepitant, je prekurzor aprepitantu.
the active substance in ivemend, fosaprepitant, is a ‘prodrug’ of aprepitant.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Účinná látka v lieku ivemend, fosaprepitant, je prekurzor aprepitantu.
the active substance in ivemend, fosaprepitant, is a ‘ prodrug ’ of aprepitant.
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
fosaprepitant, proliečivo aprepitantu, sa po intravenóznom podaní rýchlo mení na aprepitant.
fosaprepitant, a prodrug of aprepitant, when administered intravenously is rapidly converted to aprepitant.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
liek ivemend obsahuje látku nazývanú fosaprepitant, ktorá sa v tele mení na aprepitant.
ivemend contains a substance called fosaprepitant which is converted in the body into aprepitant.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
fosaprepitant 150 mg, podaný vo forme jednorazovej dávky, je slabým inhibítorom cyp3a4.
fosaprepitant 150 mg, given as a single dose, is a weak inhibitor of cyp3a4.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
metabolizmus v in vitro inkubáciách s ľudskými pečeňovými preparátmi bol fosaprepitant rýchlo konvertovaný na aprepitant.
metabolism fosaprepitant was rapidly converted to aprepitant in in vitro incubations with liver preparations from humans.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
v interakčnej štúdii s midazolamom fosaprepitant v jednorazovej dávke 150 mg neindukoval cyp3a4 v deň 1 a 4.
the fosaprepitant 150 mg single dose did not induce cyp3a4 on days 1 and 4 in the midazolam interaction study.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
u ľudí sa intravenózne podaný fosaprepitant rýchlo zmenil na aprepitant v priebehu 30 minút po ukončení podávania infúzie.
in humans, fosaprepitant administered intravenously was rapidly converted to aprepitant within 30 minutes following the end of infusion.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
fosaprepitant je proliečivo aprepitantu a po intravenóznom podaní sa rýchlo mení na aprepitant (pozri časť 5.2).
fosaprepitant is the prodrug of aprepitant and when administered intravenously is converted rapidly to aprepitant (see section 5.2).
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
keďže sa fosaprepitant mení na aprepitant, očakáva sa, že sa pri fosaprepitantne vyskytnú tie nežiaduce reakcie, ktoré sú spojené s aprepitantom.
since fosaprepitant is converted to aprepitant, those adverse reactions associated with aprepitant are expected to occur with fosaprepitant.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
okrem toho, fosaprepitant prešiel rýchlou a takmer úplnou konverziou na aprepitant v s9 preparátoch z iných ľudských tkanív vrátane obličiek, pľúc a ilea.
furthermore, fosaprepitant underwent rapid and nearly complete conversion to aprepitant in s9 preparations from other human tissues including kidney, lung and ileum.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
nezdá sa, že fosaprepitant alebo aprepitant interaguje s p- glykoproteínovým transportérom, čo sa preukázalo neprítomnosťou interakcie perorálneho aprepitantu s digoxínom.
fosaprepitant or aprepitant does not seem to interact with the p-glycoprotein transporter, as demonstrated by the lack of interaction of oral aprepitant with digoxin.
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
u laboratórnych zvierat spôsobil fosaprepitant v nekomerčných liekových formách vaskulárnu toxicitu a hemolýzu pri koncentráciách pod 1 mg/ml a vyšších, v závislosti od liekovej formy.
in laboratory animals, fosaprepitant in non-commercial formulations caused vascular toxicity and hemolysis at concentrations below 1 mg/ml and higher, dependent on the formulation.
Last Update: 2017-04-26
Usage Frequency: 3
Quality: